Identification of Potential Prognostic and Predictive Biomarkers for Immune-Checkpoint Inhibitor Response in Small Cell Lung Cancer

BACKGROUND: Immune-checkpoint inhibitors have propelled the field of therapeutics for small cell lung cancer (SCLC) treatment, but are only beneficial to some patients. The objective of this study was to identify valid biomarkers for good potential response to immunotherapy. MATERIAL/METHODS: We per...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Chanchan, Gu, Xuyu, Chen, Yan, Zhou, Min, Jiang, Feng, Zheng, Shiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2021
Materias:
Database Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570048/
https://www.ncbi.nlm.nih.gov/pubmed/34719665
http://dx.doi.org/10.12659/MSM.932275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570048/
https://www.ncbi.nlm.nih.gov/pubmed/34719665
http://dx.doi.org/10.12659/MSM.932275

Ejemplares similares